Wrap-up
Louis G. D'Alecy
PRESENTED BY:
Michigan Society for Medical Research
MichBio
PROGRAM COMMITTEE:
Paul Owen Ashba, Esq.
Karen Hudson
Rebecca Ellish-Stengle, M.P.H.
Special thanks to:
Terry Fracala
SPEAKERS
Louis G. D'Alecy, D.M.D., Ph.D.
MISMR, President
Dr. D'Alecy is a Professor of Physiology at the University of Michigan. His research interest is hypothesis testing in the area of normal and pathologic control and regulation of the cardiovascular system. A wide range of experimental approaches is used to evaluate the functional consequences of reduced blood flow and oxygen availability. Preventive and therapeutic interventions are pursued as well as basic mechanisms of cell damage. Whole animal studies using either anesthetized or conscious preparations are complemented by in vitro preparations, where appropriate, to test physiologically important hypotheses. Systemic hypoxia, regional ischemia and cardiac arrest/resuscitation models, in mice, rats and dogs are used sequentially and simultaneously to acquire data relevant to the resolution of clinical problems.
Michael D. Witt, PharmD, JD
MichBio, Executive Director
Dr. Witt is an experienced early-stage biomedical technology executive with knowledge regarding university medical technologies and the life sciences industry. Prior to joining MichBio, he was CEO of Technology Enterprise Development Corporation, a medical technology development company and CEO of vCure.com, Inc., a healthcare information and software company. He was also a healthcare attorney for Cox, Hodgman & Giarmarco of Troy, Michigan. He received a Doctor of Pharmacy degree from the University of California at San Francisco, and a law degree from Case Western Reserve University in Cleveland.
Pamela Paul-Shaheen, DrPH
Dr. Shaheen currently serves as the Health & Human Services Policy Advisor in the Office of the Governor. In this position, she advises Michigan's Governor on programs and policies to improve the health and welfare of Michigan residents. Dr. Shaheen was the Founding Director of the Center for Advancing Community Health. The Center's mission was to connect funders, communities, and policymakers to improve community health. The Center shapes change by building community capacity, informing policymaking, facilitating collaborative decision making and translating the knowledge it gains into practical tools and promising practices. Prior to creating and leading the Center, Dr. Shaheen served as a Senior Program Director with the Michigan Public Health Institute.
Robert Todd, M.D., Ph.D.
Dr. Todd is the Frances and Victor Ginsberg Professor of Hematology/Oncology and chief of the Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School. He also serves as Associate Vice President for Research (Health Affairs), Office of the Vice President for Research (OVPR), University of Michigan. Among his responsibilities on behalf of the OVPR, Dr. Todd participated in the planning and initial development of the Core Technology Alliance, the subject of his keynote talk. He was appointed to the medicine faculty of Harvard in 1981 before moving to the University of Michigan in 1984 as associate professor of internal medicine. The focus of Dr. Todd's scientific efforts at Harvard and Michigan was the identification and characterization of human leukocyte receptors involved in the acute inflammatory response. Dr. Todd is a practicing medical oncologist with expertise in lung and gastrointestinal oncology.
David C. Hollister
Department of Labor, Economic Development and Urban Growth, Director
Former Lansing Mayor David Hollister joins the Granholm Administration to direct a new agency that will combine the Department of Consumer and Industry Services with the Department of Career Development. Hollister, a former teacher, county commissioner and state representative, has served as mayor since 1994 and has overseen tremendous economic successes in Michigan's capitol city.
